Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design

Chemical Reviews

Volumn 108, Issue 11, 2008, Pages 4899-4914

  Weissbuch, Isabelle ^a   Leiserowitz, Leslie ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; BINDING ENERGY; BINDING SITES; BIOCHEMISTRY; CRYSTAL GROWTH; CRYSTALLINE MATERIALS; CRYSTALLIZATION; CRYSTALLOGRAPHY; CRYSTALS; FUNCTIONAL GROUPS; GLYCEROL; GRAIN BOUNDARIES; GROWTH (MATERIALS); METHANOL; MOLECULAR STRUCTURE; NUCLEATION; PORPHYRINS; QUANTUM CHEMISTRY;

ANTIMALARIAL DRUGS; ARTEMISININ; CAPPING AGENTS; CRYSTAL ALIGNMENTS; CRYSTAL FACES; CRYSTAL GROWTH INHIBITIONS; CRYSTAL GROWTH INHIBITORS; CRYSTAL MORPHOLOGIES; CYCLIC DIMERS; DRUG ACTIONS; EXPERIMENTAL EVIDENCES; FUTURE WORKS; GROWING CRYSTALS; LIPID BODIES; MOLECULAR DIMERS; NUCLEATION AND GROWTHS; NUCLEATION PROCESSES; PHENANTHRENE DERIVATIVES; PORPHYRIN RINGS; PRINCIPAL DIRECTIONS; SPATIAL ARRANGEMENTS; STEREOSPECIFICALLY; SURFACE BINDINGS;

CRYSTAL STRUCTURE;

ANTIMALARIAL AGENT; HEMIN; HEMOPROTEIN; HEMOZOIN;

ANIMAL; CHEMISTRY; CRYSTALLIZATION; DRUG DESIGN; HUMAN; MALARIA; METABOLISM; REVIEW;

ANIMALS; ANTIMALARIALS; CRYSTALLIZATION; DRUG DESIGN; HEMEPROTEINS; HEMIN; HUMANS; MALARIA;

EID: 57349092438     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/cr078274t     Document Type: Review

References (77)

1. Uhlemann, A. C.; Krishna, S. In Drugs, Disease and Post-genomic Biology, Current Topics in Microbiology and Immunology; Sullivan, D. J., Krishna, S., Eds.; Springer-Verlag: Berlin, Heidelberg, 2005; Vol. 295.
2. Bouland, P. B. Drug Resistance in Malaria; World Health Organization: Switzerland, 2001.
3. Ziegler, J.; Linck, R.; Wright, D. W. Curr. Med. Chem. 2001, 8, 171.
4. Egan, T. J.; Mavuso, W. W.; Ncokazi, K. K. Biochemistry 2001, 40, 204.
5. Hempelmann, E.; Egan, T. J. Trends Parasitol. 2002, 18, 11.
6. Oaks, S. C., Jr., Mitchell, V. S., Pearson, G. W., Aarpenter, C. C. J., Eds. Malaria. Obstacles and Opportuinities; National Academy Press: Washington, DC, 1991.
7. Bray, P. G.; Ward, S. A.; O'Neill, P. M. In Drugs, Disease and Post-genomic Biology, Current Topics in Microbiology and Immunology; Sullivan, D. J., Krishna, S., Eds.; Springer-Verlag: Berlin, Heidelberg, 2005; Vol. 295.
8. Scholl, P. E.; Tripathi, A. K.; Sullivan, D. J. In Drugs, Disease and Post-genomic Biology, Current Topics in Microbiology and Immunology; Sullivan, D. J., Krishna, S., Eds.; Springer-Verlag: Berlin, Heidelberg, 2005; Vol. 295.
9. Goldberg, D. E. In Drugs, Disease and Post-genomic Biology, Current Topics in Microbiology and Immunology; Sullivan, D. J., Krishna, S., Eds.; Springer-Verlag: Berlin, Heidelberg, 2005; Vol. 295.
10. Wiesner, J.; Ortmann, R.; Jomaa, H.; Schlitzer, M. Angew. Chem., Int. Ed. 2003, 42, 5274.
11. Egan, T. J. Targets 2003, 2, 115.
12. Slater, A. F. G.; Swiggart, W. J.; Orton, B. R.; Flitter, W. D.; Goldberg, D. E.; Cerami, A.; Henderson, G. B. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 325.
13. Pagola, S.; Stephens, W. P.; Bohle, D. S.; Kosar, A. D.; Madsen, S. K. Nature 2000, 404, 307.
14. Oliveira, M. F.; Kycia, S. W.; Gomez, A.; Kosar, A. J.; Bohle, D. S.; Hempelmann, E.; Menezes, D.; Vannier-Santos, M. A.; Oliveira, P. L.; Ferreira, S. T. FEBS Lett. 2005, 579, 6010.
15. Sullivan, D. J.; Gluzman, I. Y.; Russell, D. G.; Goldberg, D. E. Proc. Nutl. Acad. Sci. U.S.A. 1996, 93, 11865.
16. Sullivan, D. J.; Matile, H.; Ridley, R. G.; Goldberg, D. E. J. Biol. Chem. 1998, 273, 31103.
17. Egan, T. J.; Ross, D. C.; Adams, P. A. FEBS Lett. 1994, 352, 54.
18. Egan, T. J.; Mavuso, W. W.; Ross, D. C.; Marques, H. M. J. Inorg. Biochem. 1997, 68, 137.
19. Hawley, S. R.; Bray, P. G.; Mungthin, M.; Atkinson, J. D.; O'Neill, P. M.; Ward, S. A. Antimicrob. Agents Chemother. 1998, 42, 682.
20. Dorn, A.; Vippagunta, S. R.; Matile, H.; Jaquet, C.; Vennerstrom, J. L.; Ridley, R. G. Biochem. Pharmacol. 1998, 55, 727.
21. Chen, M. M.; Shi, L.; Sullivan, D. J. Mol. Biochem. Parasitol. 2001, 113, 1.
22. Hartman, P.; Perdok, W. G. Acta Crystallogr. 1955, 8, 49.
23. Hartman, P.; Perdok, W. G. Acta Crystallogr. 1955, 8, 525.
24. Hartman, P. In North-Holland Series in Crystal Growth; Bardsley, W., Hurle, D. T. J., Mullin, J. B., Eds.; North-Holland Publishing Co.: Amsterdam, 1973; Vol. 1.
25. Hartman, P.; Bennema, P. J. Cryst. Growth 1980, 49, 145.
26. Buller, R.; Peterson, M. L.; Almarsson, O.; Leiserowitz, L. Cryst. Growth Des. 2002, 2, 553.
27. Noland, G. S.; Briones, N.; Sullivan, D. J. Mol. Biochem. Parasitol. 2003, 130, 91.
28. Bottle, D. S.; Kosar, A. D.; Stephens, W. P. Acta Crystallogr. 2002, D58, 1752.
29. Solomonov, I.; Osipova, M.; Feldman, Y.; Baehtz, C.; Kjaer, K., Robinson, I. K.; Webster, G. T.; McNaughton, D.; Wood, B. R.; Weissbuch, I.; Leiserowitz, L. J. Am. Chem. Soc. 2007, 129, 2615.
30. Weissbuch, I.; Lahav, M.; Leiserowitz, L. Cryst. Growth Des. 2003, 3, 125.
31. DeVries, A. L. Philos. Trans. R. Soc. 1984, 304, 575.
32. Chakrabartty, A.; Yang, D. S. C.; Hew, C. L. J. Biol. Chem. 1984, 264, 11313.
33. Knight, C. A.; Chang, C. C.; DeVries, A. L. Biophys. J. 1991, 59, 409.
34. Weissbuch, I.; Addadi, L.; Labav, M.; Leiserowitz, L. Science 1991, 253, 637.
35. Weissbuch, I.; Popovitz-Biro, R.; Lahav, M.; Leiserowitz, L. Acta Crystallogr. 1995, B51, 115.
36. Poser, C. M.; Bruyn, G. W. An Illustrated History of Malaria; The Parthenon Publishing Group: New York, London, 1999.
37. Verdier, F.; Lebras, J.; Clavier, F.; Hatin, I.; Blayo, M. C. Antimicrob. Agents Chemother. 1985, 27, 561.
38. Fitch, C. D. Science 1970, 169, 289.
39. Moreau, S.; Perly, B.; Chachaty, C.; Deleuze, C. Biochimie 1982, 64, 1015.
40. O'Neill, P. M.; Willock, D. J.; Hawley, S. R.; Bray, P. G.; Storr, R. C.; Ward, S. A.; Park, B. K. J. Med. Chem. 1997, 40, 437.
41. Desiraju, G. R.; Steiner, T. The Weak Hydrogen Bond in Structural Chemistry and Biology; Oxford University Press: Oxford, NY, 1999.
42. de Villiers, K. A.; Marques, H. M.; Egan, T. J. J. Inorg. Biochem. 2008, 102, 1660.
43. Burgess, S. J.; Selzer, A.; Kelly, J. X.; Smilkstein, M. J.; Riscoe, M. K.; Peyton, D. H. J. Med. Chem. 2006, 49, 5623.
44. Wood, B. R.; Langford, S. J.; Cooke, B. M.; Lim, J.; Glenister, F. K.; Duriska, M.; Unthank, J. K.; McNaughton, D. J. Am. Chem. Soc. 2004, 126, 9233.
45. Kelly, J. X.; Winters, R.; Peyton, D. H.; Hinrichs, D. H.; Riscoe, M. Antimicrob. Agents Chemother. 2002, 46, 144.
46. Riscoe, M.; Kelly, J. X.; Winter, R. Curr. Med. Chem. 2005, 12, 2539.
47. Stead, A. M. W.; Bray, P. G.; Edwards, I. G.; Dekoning, H. P.; Elford, B. C.; Stocks, P. A.; Ward, S. A. Mol. Pharmacol. 2001, 59, 1298.
48. Meshnick, S. H. Int. J. Parasitol. 2002, 32, 1655.
49. Hong, Y. L.; Yang, Y. Z.; Meshnick, S. R. Mol. Biochem. Parasitol. 1994, 63, 121.
50. Pandey, A. V.; Tekwani, B. L.; Singh, R. L.; Chauhan, V. S. J. Biol. Chem. 1999, 274, 19383.
51. Robert, A.; Coppel, Y.; Meunier, B. Chem. Commun. 2002, 414.
52. Nader, F.; Leiserowitz, L. Acta Crystallogr. B 1977, 33, 3670.
53. Hawley, S. R.; Bray, P. G.; Park, B. K.; Ward, S. A. Mol. Biochem. Parasitol. 1996, 80, 15.
54. Hawley, S. R.; Bray, P. B.; O'Neill, P. M.; Park, P. K.; Ward, S. A. Biochem. Pharmacol. 1996, 52, 723.
55. Efremenko, I. Unpublished PBEO/sdd computations.
56. Berkovitch-Yellin, Z.; Leiserowitz, L. Acta Crystallogr. 1984, B40, 159.
57. Slouf, M.; Holy, A.; Petricek, V.; Cisarova, I. Acta Crystallogr. 2002, B58, 519.
58. Shanks, G. D.; Kain, K. C.; Keystone, J. C. Clin. Infect. Dis. 2001, 33, 381.
59. Jacquemain, D.; Wolf, S. G.; Leveiller, F.; Frolow, F.; Eisenstein, M.; Lahav, M.; Leiserowitz, L. J. Am. Chem. Soc. 1992, 114, 9983.
60. Berkovitch-Yellin, Z.; Leiserowitz, L. Acta Crystallogr. B 1977, 33, 3670.
61. Berkovitch-Yellin, Z.; Leiserowitz, L. J. Am. Chem. Soc. 1977, 99, 6106.
62. Ridley, R. G.; Holheinz, W.; Matile, H.; Aquet, C.; Dom, A.; Masciardi, R.; Jolidon, S.; Richter, W. F.; Guenzi, A.; Girometta, M.-A.; Urwyler, H.; Huber, W.; Haithong, S. T.; Peters, W. Antimicrob. Agents Chemother. 1996, 40, 1846.
63. 50 (inhibitory concentration 50) is the concentration of a compound needed to reduce the population growth of organisms.
64. deVries, P. J.; Birch, N. N.; Thien, H. V.; Hung, L. N.; Anh, T. K.; Kager, P. A.; Heisterkamp, S. H. Antimicrob. Agents Chemother. 2000, 44, 1302.
65. Gupta, S.; Thapar, M. M.; Mariga, S. T.; Wernsdorfer, W. H.; Bjorkman, A. Exp. Parasitol. 2002, 100, 28.
66. Olliaro, P. L.; Taylor, W. R. J. Postgrad. Med. 2004, 50, 40.
67. Goldberg, D. E.; Slater, A. F. G.; Cerami, A.; Henderson, G. B. Proc. Natl Acad Sci. U.S.A. 1990, 87, 2931.
68. Sullivan, D. J.; Gluzman, I. Y.; Goldberg, D. E. Science 1996, 271, 219.
69. Egan, T. E. J. Inorg. Biochem. 2002, 91, 19.
70. Bendrat, K.; Berger, B. J.; Cerami, A. Nature 1995, 378, 138.
71. Jackson, K. E.; Klonis, N.; Ferguson, D. J. P.; Adisa, A.; Dogovski, C.; Tilley, L. Mol. Microbiol. 2004, 54, 109.
72. Palacpac, N. M. Q.; Hiramine, Y.; Mi-ichi, F.; Torii, M.; Kita, K.; Hiramatsu, R.; Horii, T.; Mitamura, T. J. Cell Sci. 2004, 117, 1469.
73. Egan, T. J. J. Inorg. Biochem. 2008, 102, 1288.
74. Pisciotta, J. M.; Coppens, I.; Tripathi, A. K.; Scholl, P. F.; Schuman, J.; Bajad, S.; Shulaev, V.; Sullivan, D. J. Biochem. J. 2007, 402, 197.
75. Trager, W. Trends Parasitol. 2003, 19, 388.
76. Fitch, C. D.; Cai, G. Z.; Shen, Y, F.; Shoemaker, J. D. Biochim. Biophys. Acta, Mol. Basis Dis. 1999, 1454, 31.
77. Egan, T. J.; Chen, J. Y.-J.; de Villiers, K. A.; Mabotha, T. E.; Naidoo, K. J.; Ncokazia, K. K.; Langford, S. J.; McNaughton, D.; Pandiancherri, S.; Wood, B. R. FEBS Lett. 2006, 580, 5105.